Recruiting

The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.

ClinicalTrials.gov IDNCT07067710

PhaseNA

Enrollment108

SponsorFundacion Miguel Servet

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Cancer Survivor

About this study

The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.

Interventions

Other: Motor imagery combined with action observation — To observe and imaging one action with a video resource. Not virtual reality.

Primary outcomes

Sthrength (From enrollement to the end of the treatment at 6 weeks and 3 month after)
Range of Motion (From enrollement to the end of the treatment at 6 weeks and 3 month after)
Pain intensity (From enrollement to the end of the treatment at 6 weeks and 3 month after)
Limb diameter (From enrollement to the end of the treatment at 6 weeks and 3 month after)
Fear of movement (From enrollement to the end of the treatment at 6 weeks and 3 month after)
Imagery (From enrollement to the end of the treatment at 6 weeks and 3 month after)

Eligibility information

Inclusion Criteria: * Female, over 18 years, have suffered breast cancer, have ended active treatments (chemotherapy, radiotherapy, surgery), have pain or functional limitation or lymphedema at upper limb afected. Exclusion Criteria: * males, people with active treatments ongoning, other types of cancer, recurrence or metastasis of cancer

Study locations

Public University of Navarre, Pamplona, Navarre 31008 Spain
Public University of Navarre, Pamplona, Navarre 31008 Spain
Public University of Navarre, Pamplona, Navarre 31008 Spain

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.